#TamifluSeason The US Food and Drug Administration (FDA) has approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension 6 mg(base)/mL, made by Nesher Pharmaceuticals LLC.
"This first generic is of particular importance in patients that are not able to ingest capsules," the FDA said.
Generic oseltamivir phosphate for oral suspension comes in three doses, 30 mg, 45 mg, and 75 mg, and is indicated for patients aged 2 weeks and older who have had flu symptoms for no more than 48 hours. It is also indicated for the preventiion of influenza in patients aged 1 year and older. (Credit: Medscape) #Flu #Fluseason #Virus #InfectiousDiseases #ID #Tamiflu #Oseltamivir